| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/09/1989 | WO1989001975A1 Recombinant antibodies and methods for their production |
| 03/09/1989 | WO1989001974A1 Recombinant antibody |
| 03/09/1989 | WO1989001973A2 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/09/1989 | WO1989001972A1 Virus-resistant transgenic animals |
| 03/09/1989 | WO1989001968A1 Aprotinin homologues and process for the production of aprotinin and aprotinin homologues in yeast |
| 03/09/1989 | WO1989001947A1 Protein derived from living body |
| 03/09/1989 | WO1989001946A1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 03/09/1989 | WO1989001945A1 Follistatin and method of purifying same |
| 03/09/1989 | WO1989001943A1 Peptide complexes having enhanced stability |
| 03/09/1989 | WO1989001942A1 Polypeptides with fibronectin activity |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/09/1989 | WO1989001785A1 Monoclonal antibodies to a plasmodium falciparum protein |
| 03/09/1989 | WO1989001784A1 Production of immunoproximity catalysts |
| 03/09/1989 | WO1989001783A2 Recombinant antibody and method |
| 03/09/1989 | WO1989001782A1 Recombinant antibody |
| 03/09/1989 | WO1989001779A1 Molecular decoyants and methods of use thereof |
| 03/09/1989 | WO1989001773A1 Synovial phospholipases |
| 03/08/1989 | EP0306473A1 Pharmaceutical structure with protein-supported agents |
| 03/08/1989 | EP0306470A1 DNA molecules encoding bovine placental lactogen peptide and pre-peptide and genetically transformed cells comprising these molecules |
| 03/08/1989 | EP0306360A1 Method for the preparation of antigenic fractions used in the detection of antibodies indicative of cardiovascular trouble, antigenic fractions thus obtained and their use in the diagnosis of a cardiovascular risk |
| 03/08/1989 | EP0306318A1 Recombinant DNA-derived bordetella toxin subunit analogs |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0305967A2 Conjugates of interferon alpha with immunoglobulins |
| 03/08/1989 | EP0305960A2 A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use |
| 03/08/1989 | EP0305870A2 Production of immunoproximity catalysts |
| 03/08/1989 | EP0305777A2 Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents |
| 03/08/1989 | EP0305760A2 Method of isolating basic proteins from a protein mixture |
| 03/08/1989 | EP0305615A1 Peptide antagonists for the C5a anaphylatoxin |
| 03/08/1989 | EP0305500A1 Process for the purification of recombinant polypeptides. |
| 03/08/1989 | EP0305401A1 Combinations having synergistic growth hormone releasing activity and methods for use thereof. |
| 03/08/1989 | CN1031538A Process for reducing methionine sulfoxide residues |
| 03/07/1989 | US4810780 Protein having phospholipase A2 inhibitory activity |
| 03/07/1989 | US4810777 Antimicrobial compounds |
| 03/07/1989 | US4810692 Cyclodeposipeptides |
| 03/07/1989 | US4810691 Polypeptide cartilage-inducing factors found in bone |
| 03/07/1989 | US4810645 Microbial production of mature human leukocyte interferon K and L |
| 03/07/1989 | US4810643 Production of pluripotent granulocyte colony-stimulating factor |
| 03/07/1989 | US4810634 Pseudorabies virus mutants incapable of producing glycoprotein X |
| 03/07/1989 | US4810494 Canine parvovirus vaccines |
| 03/07/1989 | US4810492 Vaccine against japanese encephalitis |
| 03/07/1989 | US4810491 Polypeptides useful in vaccination against enteroviruses |
| 03/07/1989 | CA1250810A1 Hexapeptide, method for making same, and pharmaceuticals containing it |
| 03/01/1989 | EP0305320A2 Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them |
| 03/01/1989 | EP0305283A2 Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof |
| 03/01/1989 | EP0305279A1 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 03/01/1989 | EP0305275A2 Plants transformed with a DNA sequence from Bacillus thuringiensis |
| 03/01/1989 | EP0305243A1 Protein concentrate coagulable by thrombin, purification process and therapeutic application |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 03/01/1989 | EP0304971A2 A method of producing a polypeptide having the protease inhibition activity of mammalan alpha-1-antitrypsin |
| 03/01/1989 | EP0304628A2 Immunoassay for CK-MM isoenzymes |
| 03/01/1989 | EP0304578A1 Peptide comprising hepatitis B surface antigen |
| 03/01/1989 | EP0304486A1 Production of bioadhesive precursor protein analogs by genetically-engineered organisms |
| 03/01/1989 | CN1031396A New toxin-encoding dna fragments from bacillus thuringiensis subsp, israellensis |
| 03/01/1989 | CN1031395A Hepatitis b virus surface antigens and hybrid antigens containing them |
| 03/01/1989 | CN1031379A Polypeptide and method for preparing same, kyosuke |
| 02/28/1989 | US4808702 Isolated from mussels; enzymatically digested |
| 02/28/1989 | US4808701 Cyclic peptides having appetite regulating activity |
| 02/28/1989 | US4808700 Vaccine for immunization of young mammals against infections |
| 02/28/1989 | US4808611 Stimulation of blood-producing cells |
| 02/28/1989 | US4808573 Angiotensin converting enzyme inhibitors |
| 02/28/1989 | US4808536 Human t-cell lymphotropic virus; acquired immunodeficiency syndrome; in kit form; screening |
| 02/28/1989 | US4808533 Method of preventing T-cell blastogenesis |
| 02/28/1989 | US4808523 Constitutive production of human IFN-β1 by mammalian cells transformed by the IFN-β1 gene fused to an SV40 early promoter |
| 02/28/1989 | US4808405 P-anisoyl streptokinase/plasminogen complex |
| 02/28/1989 | US4808314 Method for reducing bacterial endotoxin contamination in solutions of macromolecules |
| 02/28/1989 | CA1250700A1 Glycopeptide derivatives |
| 02/28/1989 | CA1250587A1 Method and agents for measuring protein aging |
| 02/28/1989 | CA1250524A1 Preparation and use of enzyme-detergent extracted streptococcus equi vaccine |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001519A1 Human mannose binding protein |
| 02/23/1989 | WO1989001517A1 Vector for integration site independent gene expression in mammalian host cells |
| 02/23/1989 | WO1989001516A1 Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus |
| 02/23/1989 | WO1989001515A2 Plants transformed with a dna sequence from bacillus thuringiensis |
| 02/23/1989 | WO1989001514A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
| 02/23/1989 | WO1989001511A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
| 02/23/1989 | WO1989001494A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 02/23/1989 | WO1989001493A1 Polypeptides with laminin activity |
| 02/23/1989 | WO1989001492A1 Novel polypeptide and method for preparing the same |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/23/1989 | WO1989001489A1 Control of angiogenesis and compositions and methods therefor |
| 02/23/1989 | WO1989001488A1 Renin inhibiting peptides with nonpeptide linkages |
| 02/23/1989 | WO1989001487A1 Removal of n-terminal acylated amino acid residues from polypeptides |
| 02/23/1989 | WO1989001486A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 02/23/1989 | WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier |
| 02/23/1989 | WO1989001339A1 Hyper-immune globulin against hiv |
| 02/23/1989 | WO1989001335A1 Biospecific polymers |
| 02/23/1989 | WO1989000582A3 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 02/23/1989 | DE3727011A1 Type II diabetes mellitus selective treatment - using DES-B25-30-hexa:peptide insulin or corresp. opt. N-substd. B24 amide(s) |
| 02/22/1989 | EP0304311A1 Complex of polyethylene glycol and tissue plasminogen activator |
| 02/22/1989 | EP0304292A2 Antibody to propeptide of procollagen type III, and assay method using it |
| 02/22/1989 | EP0304279A2 Peptide determinant associated with immunity |
| 02/22/1989 | EP0304161A2 Separation of immunoglobulin G subclasses |
| 02/22/1989 | EP0304021A2 Acylamino acid racemase, Production and use thereof |
| 02/22/1989 | EP0304013A2 A novel senile amyloid precursor protein and an antibody specific for the same |
| 02/22/1989 | EP0303983A2 Synthetic peptides, antibodies directed against them and their use |
| 02/22/1989 | EP0303972A2 Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids |
| 02/22/1989 | EP0303859A2 Cloning of DNA encoding antibacterial polypeptide precursor and expression of the precursor |
| 02/22/1989 | EP0303858A2 Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor |
| 02/22/1989 | EP0303817A2 A process for preparing a calcium-dependent oxygenase |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |